UB Paderborn / Katalog / Suche / in CDI

1 – 18 von 18

Sortiert nach

Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018)

Journal of global antimicrobial resistance., 2022-12, Vol.31, p.82-89

2022

Volltextzugriff (PDF)

Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program

Antimicrobial agents and chemotherapy, 2021-03, Vol.65 (4)

2021

Volltextzugriff (PDF)

In vitro Activity of Isavuconazole and Comparators Against Clinical Isolates of Molds from a Multicenter Study in China

Infection and drug resistance, 2022-04, Vol.15, p.2101-2113

2022

Volltextzugriff (PDF)

A current and historical perspective on disparities in US childhood pneumococcal conjugate vaccine adherence and in rates of invasive pneumococcal disease: Considerations for the routinely-recommended, pediatric PCV dosing schedule in the United States

Human vaccines & immunotherapeutics, 2016-01, Vol.12 (1), p.206-212

2016

Volltextzugriff (PDF)

mRNA Subtractive Hybridization for the Isolation and Identification of Tissue Culture-Induced Determinants from Haemophilus influenzae Biogroup Aegyptius, the Causative Agent of Brazilian Purpuric Fever

Annals of the New York Academy of Sciences, 1994-09, Vol.730 (1), p.269-272

1994

Volltextzugriff (PDF)

A Tissue Culture Model for Studying the Pathogenesis of Brazilian Purpuric Fever

Annals of the New York Academy of Sciences, 1994-09, Vol.730 (1), p.260-262

1994

Volltextzugriff (PDF)

In vitro activity of ceftazidime-avibactam and comparators against OXA-48-like Enterobacterales collected between 2016 and 2020

Microbiology spectrum, 2024-03, Vol.12 (3), p.e0147323-e0147323

2024

Volltextzugriff (PDF)

Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Study, 2018 to 2019

Antimicrobial agents and chemotherapy, 2023-05, Vol.67 (5), p.e0140622-e0140622

2023

Volltextzugriff (PDF)

Ceftazidime-avibactam and comparators against Pseudomonas aeruginosa isolates collected globally and in each geographical region between 2017–2020

Journal of global antimicrobial resistance., 2023-09, Vol.34, p.113-118

2023

Volltextzugriff (PDF)

Evaluation of in vitro activity of ceftaroline against pathogens associated with community-acquired pneumonia: ATLAS program 2017–2019

Journal of global antimicrobial resistance., 2023-06, Vol.33, p.360-367

2023

Volltextzugriff (PDF)

In Vitro Activity of Ceftaroline and Comparators against Bacterial Isolates Collected Globally from Patients with Skin and Soft Tissue Infections: ATLAS Program 2019–2020

Antibiotics (Basel), 2023-07, Vol.12 (8), p.1237

2023

Volltextzugriff (PDF)

Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017–2019

Journal of antimicrobial chemotherapy, 2023-07, Vol.78 (7), p.1606-1615

2023

Volltextzugriff (PDF)

Design of a Brushless Doubly-Fed Machine for Aviation Electric Propulsion

IEEE transactions on industry applications, 2022-09, Vol.58 (5), p.6057-6068

2022

Volltextzugriff (PDF)

In vitro Activity of Ceftaroline Against Isolates of Gram-Positive Bacteria from Patients with Bloodstream Infections Collected as a Part of ATLAS Between 2017 and 2020

Infection and drug resistance, 2024-01, Vol.17, p.343-354

2024

Volltextzugriff (PDF)

Ceftazidime-avibactam activity against Gram-negative respiratory isolates collected between 2018 and 2019

Journal of global antimicrobial resistance., 2022-12, Vol.31, p.239-247

2022

Volltextzugriff (PDF)

The global response to the threat of antimicrobial resistance and the important role of vaccines

Pharmaceuticals policy and law, 2016-11, Vol.18 (1-4), p.179-197

2016

Volltextzugriff (PDF)

Cancer risk in living kidney donors

American journal of transplantation, 2022-08, Vol.22 (8), p.2006-2015

2022

Volltextzugriff (PDF)

A Turboelectric Distributed Propulsion Based On Brushless Doubly-Fed Machines

2020 IEEE Energy Conversion Congress and Exposition (ECCE), 2020, p.6359-6366

2020

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)

Publikationsform

Artikel
(17)
Tagungsberichte
(1)

Sprache

Englisch
(18)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018)

Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program

In vitro Activity of Isavuconazole and Comparators Against Clinical Isolates of Molds from a Multicenter Study in China

A current and historical perspective on disparities in US childhood pneumococcal conjugate vaccine adherence and in rates of invasive pneumococcal disease: Considerations for the routinely-recommended, pediatric PCV dosing schedule in the United States

mRNA Subtractive Hybridization for the Isolation and Identification of Tissue Culture-Induced Determinants from Haemophilus influenzae Biogroup Aegyptius, the Causative Agent of Brazilian Purpuric Fever

A Tissue Culture Model for Studying the Pathogenesis of Brazilian Purpuric Fever

In vitro activity of ceftazidime-avibactam and comparators against OXA-48-like Enterobacterales collected between 2016 and 2020

Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Study, 2018 to 2019

Ceftazidime-avibactam and comparators against Pseudomonas aeruginosa isolates collected globally and in each geographical region between 2017–2020

Evaluation of in vitro activity of ceftaroline against pathogens associated with community-acquired pneumonia: ATLAS program 2017–2019

In Vitro Activity of Ceftaroline and Comparators against Bacterial Isolates Collected Globally from Patients with Skin and Soft Tissue Infections: ATLAS Program 2019–2020

Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017–2019

Design of a Brushless Doubly-Fed Machine for Aviation Electric Propulsion

In vitro Activity of Ceftaroline Against Isolates of Gram-Positive Bacteria from Patients with Bloodstream Infections Collected as a Part of ATLAS Between 2017 and 2020

Ceftazidime-avibactam activity against Gram-negative respiratory isolates collected between 2018 and 2019

The global response to the threat of antimicrobial resistance and the important role of vaccines

Cancer risk in living kidney donors

A Turboelectric Distributed Propulsion Based On Brushless Doubly-Fed Machines

Aktive Filter

Suchergebnisse filtern